SCHEMBL3640930

SCHEMBL3640930

O=C(O)c1nc2c(Br)cccc2s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
DYRK1A Q13627 2/20 0.39
PDPK1 O15530 1/20 0.39
LIPG Q9Y5X9 1/20 0.38
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 2/20 0.36
PKM P14618 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
BCL2L1 Q07817 1/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28368237 0.85 MAPT (0.41) MAPTL3MBTL1CASP3SENP8SENP7
SCHEMBL29749250 0.85 MAPT (0.41) MAPTL3MBTL1CASP3SENP8SENP7
SCHEMBL28901461 0.84 PDE10A (0.47) MAPTL3MBTL1CASP3SENP8SENP7
SCHEMBL28368126 0.81 ALDH1A1 (0.59) MAPTCASP3SENP8SENP7SENP6
SCHEMBL29749248 0.81 ALDH1A1 (0.59) MAPTCASP3SENP8SENP7SENP6
SCHEMBL29929393 0.81 ALDH1A1 (0.47) MAPTDYRK1APDPK1SMN1; SMN2HPGD
SCHEMBL2116026 0.79 SMN1; SMN2 (0.54) MAPTL3MBTL1CASP3SENP8SENP7
SCHEMBL3627491 0.79 DYRK1A (0.39) MAPTDYRK1APDPK1NPC1RAB9A
SCHEMBL2212181 0.79 ALDH1A1 (0.54) MAPTL3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL20893420 0.77 MEN1 (0.53) MAPTDYRK1APDPK1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2167077-A2 ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR Bayer Schering Pharma Aktiengesellschaft (DE) 2010-03-31 EP claimed
WO-2008152099-A2 ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO claimed
CN-110770233-B Fused bicyclic compound and application thereof in medicine 广东东阳光药业有限公司 2022-07-26 CN disclosed
CN-110770233-A Fused bicyclic compound and application thereof in medicine 广东东阳光药业有限公司 2020-02-07 CN disclosed